NL-OMON26011尚未招募不适用
Intravenous treatment with Mitoxantrone in active secondary progressive multiple sclerosis: effects on adaptive immune system.
R. HuppertsOrbis Medical CenterDepartment of NeurologyPostbus 55006130 MB Sittard-Geleen0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Secondary progressive MS patients who are treated with mitoxantrone according to normal neurological practice;
- •2. Age 18-65;
排除标准
- •1. Relapsing remitting multiple sclerosis;
- •2. Treatment with intravenous corticosteroids in the last 30 days;
研究者
相似试验
Unknown
4 期
Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum DisordersNeuromyelitis Optica Spectrum DisordersNeuromyelitis OpticaNCT02021825Xuanwu Hospital, Beijing50
已完成
2 期
Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic LymphomasLymphoma, Non-HodgkinHIV InfectionsNCT00002003Lederle Laboratories
进行中（未招募）
不适用
MITOXANTRONE/GLATIRAMER ACETATE COMBINED TREATMENT IN THE THERAPY OF SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS - aMICO STUDYsubjects affected by secondary-progressive Multiple SclerosisMedDRA version: 9.1Level: SOCClassification code 10029205EUCTR2009-010661-23-ITAZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
尚未招募
1 期
CMOEP in the Treatment of Untreated Peripheral T-cell LymphomaPeripheral T-cell LymphomaNCT05458180Tianjin Medical University Cancer Institute and Hospital18
已完成
不适用
Evaluation the effect of adding methylprednisolone to mitoxantrone on progressive multiple sclerosis treatmentMultiple Sclerosis.Demyelinating diseases of the central nervous systemIRCT201107145943N3Yazd University of Medical Sciences70